1,000 units of marijuana medicine sent to US-based trial in a clinical setting
Over the course of the last few months, a pharmaceutical giant MGC Pharma (ASX:MXC) has stated out loud that a $24 million supply of cannabis based products partnered with AMC Holdings (a pharna comp. unrelated to the king pin) will be available.
View the rest of the story here: https://www.ponderingpot.com.au/national/mgc-pharma-asx-mxc-to-send-1000-units-of-cannabis-medicine-to-us-based-clinical-trial/
